IL144380A0 - Method of enhancing needleless transdermal powdered drug delivery - Google Patents

Method of enhancing needleless transdermal powdered drug delivery

Info

Publication number
IL144380A0
IL144380A0 IL14438000A IL14438000A IL144380A0 IL 144380 A0 IL144380 A0 IL 144380A0 IL 14438000 A IL14438000 A IL 14438000A IL 14438000 A IL14438000 A IL 14438000A IL 144380 A0 IL144380 A0 IL 144380A0
Authority
IL
Israel
Prior art keywords
enhancing
drug delivery
powdered drug
needleless transdermal
needleless
Prior art date
Application number
IL14438000A
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Publication of IL144380A0 publication Critical patent/IL144380A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
IL14438000A 1999-01-22 2000-01-21 Method of enhancing needleless transdermal powdered drug delivery IL144380A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23594499A 1999-01-22 1999-01-22
US11690799P 1999-01-22 1999-01-22
PCT/GB2000/000156 WO2000043058A1 (en) 1999-01-22 2000-01-21 Method of enhancing needleless transdermal powdered drug delivery

Publications (1)

Publication Number Publication Date
IL144380A0 true IL144380A0 (en) 2002-05-23

Family

ID=26814746

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14438000A IL144380A0 (en) 1999-01-22 2000-01-21 Method of enhancing needleless transdermal powdered drug delivery
IL144380A IL144380A (en) 1999-01-22 2001-07-17 Method of enhancing needleless transdermal powdered drug delivery

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144380A IL144380A (en) 1999-01-22 2001-07-17 Method of enhancing needleless transdermal powdered drug delivery

Country Status (6)

Country Link
EP (1) EP1148902A1 (en)
JP (1) JP2002535293A (en)
AU (1) AU765429B2 (en)
CA (1) CA2358584A1 (en)
IL (2) IL144380A0 (en)
WO (1) WO2000043058A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2361555A1 (en) 1999-02-03 2000-08-10 Powderject Research Limited Hydrogel particle formulations
FR2822049B1 (en) 2001-03-13 2003-08-01 Dbv Medica 1 PATCH INTENDED IN PARTICULAR TO DETECT THE STATE OF SENSITIZATION OF A SUBJECT TO AN ALLERGEN, METHOD OF MANUFACTURING AND USE
US7635488B2 (en) 2001-03-13 2009-12-22 Dbv Technologies Patches and uses thereof
JP2006335754A (en) * 2005-06-01 2006-12-14 Technofarm Axesz Kk Thin film carrying percutaneous absorption preparation and its manufacturing process
FR2921562B1 (en) * 2007-10-01 2012-06-15 Dbv Tech ADHESIVE DEVICE FOR SKIN APPLICATION
FR2924350B1 (en) 2007-12-03 2010-08-13 Dbv Tech METHOD AND COMPOSITIONS FOR SKIN VACCINATION
FR2924349B1 (en) 2007-12-03 2010-01-01 Dbv Tech ALLERGEN DISENSIBILITY METHOD
US8821434B2 (en) * 2010-10-07 2014-09-02 Massachusetts Institute Of Technology Delivery of a solid body and/or a fluid using a linear Lorentz-force actuated needle-free jet injection system
US20130060209A1 (en) * 2011-05-12 2013-03-07 Parker Campbell Tyler Athletic Tape
EP2979714A1 (en) * 2014-08-02 2016-02-03 LTS LOHMANN Therapie-Systeme AG Needleless injection device with a membrane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233169B1 (en) * 1971-04-14 1977-08-26
US4831023A (en) * 1986-06-27 1989-05-16 Thames Pharmacal Co., Inc. Water washable vehicles for topical use
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
CA2789115C (en) * 1996-12-31 2014-04-29 Altea Therapeutics Corporation Microporation of tissue for delivery of bioactive agents
IL120943A (en) * 1997-05-29 2004-03-28 Univ Ben Gurion Transdermal delivery system

Also Published As

Publication number Publication date
AU3065000A (en) 2000-08-07
EP1148902A1 (en) 2001-10-31
IL144380A (en) 2007-07-24
JP2002535293A (en) 2002-10-22
AU765429B2 (en) 2003-09-18
CA2358584A1 (en) 2000-07-27
WO2000043058A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
IL144730A (en) Use of statin drug in the preparation of a medicament and as a medicament for the treatment of diabetic neuropathy
AU2938100A (en) Transdermal drug delivery system and method
EP1231864A4 (en) Drug delivery catheters that attach to tissue and methods for their use
IL149224A0 (en) Hydrogen-driven drug dosage form
AU5325000A (en) Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
HK1046240A1 (en) Pharmaceutical compositions for the treatment of insulin resistance
AU1967601A (en) Drug delivery system for implantable cardiac device
EP1091732A4 (en) Effervescent drug delivery system for oral administration
GB9904629D0 (en) Oral drug delivery system
EP1450876A4 (en) Integrated transdermal drug delivery system
AU2002213698A1 (en) Needleless syringe for the subcutaneous delivery of therapeutic agents
AU3520900A (en) Implantable drug delivery system
IL149655A0 (en) Improved transdermal contraceptive delivery system and process
GB0119012D0 (en) Transdermal delivery of drugs
IL144380A0 (en) Method of enhancing needleless transdermal powdered drug delivery
IL137559A0 (en) Transdermal drug delivery system
IL149316A0 (en) Medication delivery apparatus and methods for interavenous infusions
HUP0102219A3 (en) Metered dose infusion pump and method
AU4935800A (en) Needleless injector drug capsule
GB0121628D0 (en) Improved method and apparatus for transdermal drug delivery
EP1173192A4 (en) Methods and compositions for targeted drug delivery
AU6503399A (en) Drug delivery catheter
AU3926000A (en) Methods and compositions for drug delivery
AU2001251349A1 (en) Method and device for enhanced transdermal drug delivery

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees